Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
Proteomics Core Facility, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.
Antimicrob Agents Chemother. 2019 Aug 23;63(9). doi: 10.1128/AAC.00461-19. Print 2019 Sep.
There is significant interest in the development of mass spectrometry (MS) methods for antimicrobial resistance protein detection, given the ability of these methods to confirm protein expression. In this work, we studied the performance of a liquid chromatography, tandem MS multiple-reaction monitoring (LC-MS/MS MRM) method for the direct detection of the New Delhi metallo-β-lactamase (NDM) carbapenemase in clinical isolates. Using a genoproteomic approach, we selected three unique peptides (SLGNLGDADTEHYAASAR, AFGAAFPK, and ASMIVMSHSAPDSR) specific to NDM that were efficiently ionized and spectrally well-defined. These three peptides were used to build an assay with turnaround time of 90 min. In a blind set, the assay detected 21/24 -containing isolates and 76/76 isolates with negative results, corresponding to a sensitivity value of 87.5% (95% confidence interval [CI], 67.6% to 97.3%) and a specificity value of 100% (95% CI, 95.3% to 100%). One of the missed identifications was determined by protein fractionation to be due to low (∼0.1 fm/μg) NDM protein expression (below the assay limit of detection). Parallel disk diffusion susceptibility testing demonstrated this isolate to be meropenem susceptible, consistent with low NDM expression. Total proteomic analysis of the other two missed identifications did not detect NDM peptides but detected other proteins expressed from the -containing plasmids, confirming that the plasmids were not lost. The measurement of relative NDM concentrations over the entire isolate test set demonstrated variability spanning 4 orders of magnitude, further confirming the remarkable range that may be seen in levels of NDM expression. This report highlights the sensitivity of LC-MS/MS to variations in NDM protein expression, with implications for how this technology may be used.
人们对开发用于检测抗微生物药物耐药性蛋白的质谱 (MS) 方法有着浓厚的兴趣,因为这些方法能够确认蛋白质的表达。在这项工作中,我们研究了一种用于直接检测临床分离株中新德里金属β-内酰胺酶 (NDM) 碳青霉烯酶的液相色谱-串联 MS 多重反应监测 (LC-MS/MS MRM) 方法的性能。使用基因蛋白质组学方法,我们选择了三个针对 NDM 的独特肽 (SLGNLGDADTEHYAASAR、AFGAAFPK 和 ASMIVMSHSAPDSR),这些肽具有高效的离子化和良好的光谱定义。这三个肽被用于构建一个具有 90 分钟周转时间的检测方法。在一个盲法检测中,该方法检测到了 21/24 个含有 NDM 的分离株和 76/76 个阴性分离株,其灵敏度值为 87.5%(95%置信区间 [CI],67.6%至 97.3%),特异性值为 100%(95% CI,95.3%至 100%)。一个被漏检的鉴定结果通过蛋白分级被确定为 NDM 蛋白表达水平低(∼0.1 fm/μg)(低于检测方法的检测限)。平行的纸片扩散药敏试验表明该分离株对美罗培南敏感,这与低 NDM 表达一致。对另外两个漏检的鉴定结果的全蛋白质组分析未检测到 NDM 肽,但检测到了来自含有 NDM 的质粒表达的其他蛋白质,这证实了质粒没有丢失。对整个分离株检测集的相对 NDM 浓度的测量显示,其变化范围跨越了 4 个数量级,进一步证实了 NDM 表达水平可能存在的显著差异。本报告强调了 LC-MS/MS 对 NDM 蛋白表达变化的敏感性,这对该技术的应用具有重要意义。